Filgrastim biosimilar - USVAlternative Names: Granulocyte colony stimulating factors biosmilar - USV
Latest Information Update: 11 May 2015
At a glance
- Originator USV
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor stimulants; Haematopoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neutropenia
Most Recent Events
- 11 May 2015 Preclinical trials in Neutropenia in India (SC) (USV product pipeline, May 2015)